ECO Animal Health to issue results for the year ended 31 March 2023 on 10th July 2023

ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced the disposal of ECOmectin® Horsepaste to ACME Drugs S.r.l in Italy,

ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced an update on trading and business progress for the year ending

ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced the appointment of Dr. Joachim Hasenmaier as a Non-Executive Director, with

ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced that the ECOVAXXIN® trademark has been approved by the European

ECO Animal Health Group plc (LON:EAH) has announced that on 5 January 2024 the Company completed the sale of its freehold property in New Malden, Surrey.  This was the former registered office of the Company and following

ECO Animal Health Group plc (LON:EAH) has announced that on 21 December 2023 deferred nominal cost share options were granted under the Company’s Deferred Bonus Plan (“DBS”) over 44,562 ordinary shares in the Company (representing approximately 0.07

ECO Animal Health Group plc (LON:EAH) has announced its results for the six months ended 30 September 2023. HIGHLIGHTS Financial ·      Group Revenue increased 9% to £38.0 million (H1 2022: £34.9 million) o  Revenues on a constant currency basis

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be hosting two Capital Markets events focused on progress and

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has received a new US and Canadian label claim indication for Aivlosin® Water

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has achieved an A-rating for its ESG activities from Integrum ESG, who